BE 
the Impact

BrightEdge capital and resources deliver patients access to today’s significant ways to save lives, celebrate lives, and lead the fight for a world without cancer.

As we enter an era of unprecedented innovation in new oncology technologies and therapies, BrightEdge accelerates market delivery of today’s promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer.
Women smiling in a field

You can impact the lives of cancer patients today by joining BrightEdge in bringing innovative technology and therapies to market.

BE 
the Impact

BrightEdge capital and resources deliver patients access to today’s significant ways to save lives, celebrate lives, and lead the fight for a world without cancer.

As we enter an era of unprecedented innovation in new oncology technologies and therapies, BrightEdge accelerates market delivery of today’s promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer.

You can impact the lives of cancer patients today by joining BrightEdge in bringing innovative technology and therapies to market.

You can impact the lives of cancer patients today by joining BrightEdge in bringing innovative technology and therapies to market.

Investing

Investment Strategy Across the Cancer Continuum
BrightEdge evaluates early- to late-stage capital investment opportunities in companies that meet our mission and due diligence criteria. American Cancer Society priorities in research will help frame the investments BrightEdge make including four key areas:
  • Prevention

    Smoking Cessation Technologies, Vaccines, Screening Technologies

  • Diagnostics

    Assays, Genomics. Imaging, Artificial Intelligence

  • Therapies

    Small Molecules, Immunotherapy, Gene Therapy, Precision Medicine

  • Survivorship

    Data Tracking, Care Management, Telemedicine, Surveillance Technologies